DC Chemicals · Product datasheet

IDH-305 · DC10538

IDH-305 (IDH305) is an allosteric mutant-IDH1 inhibitor for studies of 2-hydroxyglutarate production and IDH1-mutant cancer biology.

ParameterValue
Chemical Name(4R)-4-[(1S)-1-fluoroethyl]-3-(2-{[(1S)-1-[4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl]ethyl]amino}pyrimidin-4-yl)-1,3-oxazolidin-2-one
CAS No.1628805-46-8
SynonymsIDH-305
FormulaC23N6O2F4H22
M.Wt490.4534
SMILESO=C1OC[C@H]([C@@H](F)C)N1C2=NC(N[C@H](C3=CC(C)=C(C4=CC(C(F)(F)F)=NC=C4)C=N3)C)=NC=C2
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological activity summary

IDH-305 (IDH305) is an allosteric mutant-IDH1 inhibitor for studies of 2-hydroxyglutarate production and IDH1-mutant cancer biology.

View referenced In Vitro and In Vivo results on the product page

References

  1. Cho YS, et al. Discovery and Evaluation of Clinical Candidate IDH305, a Brain Penetrant Mutant IDH1 Inhibitor. ACS medicinal chemistry letters (2017).

Available packs

  • 50 mg · US$950
  • 100 mg · US$1,700
  • 250 mg · US$3,200
View product and biological activity →

Cart

Request quotation